321 related articles for article (PubMed ID: 17332446)
21. Retroactive reimbursement under HCFA's PPS for capital.
Coffey SR
Healthc Financ Manage; 1993 Oct; 47(10):60, 62, 64 passim. PubMed ID: 10145883
[TBL] [Abstract][Full Text] [Related]
22. Growth of intensive care unit resource use and its estimated cost in Medicare.
Milbrandt EB; Kersten A; Rahim MT; Dremsizov TT; Clermont G; Cooper LM; Angus DC; Linde-Zwirble WT
Crit Care Med; 2008 Sep; 36(9):2504-10. PubMed ID: 18679127
[TBL] [Abstract][Full Text] [Related]
23. DRGs and outliers in surgical critical care.
Scheeres DE; Scholten DJ
Am Surg; 1989 Aug; 55(8):511-5. PubMed ID: 2504093
[TBL] [Abstract][Full Text] [Related]
24. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
25. What proposed DRG refinements mean for hospitals. Part III.
Shoemaker P
Health Syst Rev; 1994; 27(5):6, 8-11. PubMed ID: 10137370
[No Abstract] [Full Text] [Related]
26. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
27. [Reimbursement of patients with high costs in a department of otorhinolaryngology of maximum care and refinancing by the German DRG system].
Bachor E; Neun O; Bogeschdorfer F; Gruen PM
Laryngorhinootologie; 2005 Aug; 84(8):594-601. PubMed ID: 16080062
[TBL] [Abstract][Full Text] [Related]
28. [DRG reimbursement for multiple trauma patients -- a comparison with the comprehensive hospital costs using the German trauma registry].
Grotz M; Schwermann T; Lefering R; Ruchholtz S; Graf v d Schulenburg JM; Krettek C; Pape HC
Unfallchirurg; 2004 Jan; 107(1):68-75. PubMed ID: 14749855
[TBL] [Abstract][Full Text] [Related]
29. Medicare's fee schedule for hospital outpatient care.
Grimaldi PL
J Health Care Finance; 2002; 28(3):14-31. PubMed ID: 12079149
[TBL] [Abstract][Full Text] [Related]
30. DRG reimbursement: geriatric hip fractures in the community hospital trauma center.
Clancy T; Kitchen S; Churchill P; Covington D; Hundley J; Maxwell JG
South Med J; 1998 May; 91(5):457-61. PubMed ID: 9598854
[TBL] [Abstract][Full Text] [Related]
31. Inpatient rehabilitation facilities are now paid prospective rates.
Grimaldi PL
J Health Care Finance; 2002; 28(3):32-48. PubMed ID: 12079150
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the impact of Medicare and Medicaid prospective payment on utilization of Philadelphia area hospitals.
Smith DB; Pickard R
Health Serv Res; 1986 Oct; 21(4):529-46. PubMed ID: 3095267
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of thrombolytic treatment for stroke.
Mar J; Begiristain JM; Arrazola A
Cerebrovasc Dis; 2005; 20(3):193-200. PubMed ID: 16088115
[TBL] [Abstract][Full Text] [Related]
34. Adjustment of inpatient care reimbursement for nursing intensity.
Welton JM; Zone-Smith L; Fischer MH
Policy Polit Nurs Pract; 2006 Nov; 7(4):270-80. PubMed ID: 17242392
[TBL] [Abstract][Full Text] [Related]
35. DRG, costs and reimbursement following Roux-en-Y gastric bypass: an economic appraisal.
Angus LD; Cottam DR; Gorecki PJ; Mourello R; Ortega RE; Adamski J
Obes Surg; 2003 Aug; 13(4):591-5. PubMed ID: 12935360
[TBL] [Abstract][Full Text] [Related]
36. Impact of case type, length of stay, institution type, and comorbidities on Medicare diagnosis-related group reimbursement for adult spinal deformity surgery.
Nunley PD; Mundis GM; Fessler RG; Park P; Zavatsky JM; Uribe JS; Eastlack RK; Chou D; Wang MY; Anand N; Frank KA; Stone MB; Kanter AS; Shaffrey CI; Mummaneni PV;
Neurosurg Focus; 2017 Dec; 43(6):E11. PubMed ID: 29191102
[TBL] [Abstract][Full Text] [Related]
37. Hospitalization costs for acute ischemic stroke patients treated with intravenous thrombolysis in the United States are substantially higher than medicare payments.
Brinjikji W; Rabinstein AA; Cloft HJ
Stroke; 2012 Apr; 43(4):1131-3. PubMed ID: 22198978
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
[TBL] [Abstract][Full Text] [Related]
39. Laboratory cost and utilization containment.
Steiner JW; Root JM; White DC
Clin Lab Manage Rev; 1991; 5(5):372-4, 376, 378-84. PubMed ID: 10113716
[TBL] [Abstract][Full Text] [Related]
40. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups.
Tong KB; Lau CJ; Murtagh K; Layton AJ; Seifeldin R
Int J Infect Dis; 2009 Jan; 13(1):24-36. PubMed ID: 18621562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
